Article Details
Retrieved on: 2021-05-10 15:05:26
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
ADG20 is a monoclonal antibody. Humanigen released pre-print data from its Phase III trial of lenzilumab in hospitalized COVID-19 patients. The data ...
Article found on: www.biospace.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here